- Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma(2018)
Auteurs: Nora Sundahl, Katrien De Wolf, Vibeke Kruse, Annabel Meireson, Dries Reynders, Els Goetghebeur, Mireille Van Gele, Reinhart Speeckaert, Benjamin Hennart, Lieve Brochez, et al.
Pagina's: 906 - 915
- A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma : evaluation of clinical and immunologic response(2017)
Auteurs: Katrien De Wolf, VIBEKE KRUSE, Nora Sundahl, Mireille Van Gele, Ines Chevolet, Reinhart Speeckaert, Lieve Brochez, Piet Ost
- Phase I trial of stereotactic body radiotherapy with concurrent fixed dose ipilimumab in metastatic melanoma: dose limiting toxicity and abscopal effect(2015)
Volume: 26
Auteurs: Katrien De Wolf, Piet Ost, VIBEKE KRUSE, Lieve Brochez, Ines Chevolet
Pagina's: 7 - 7
- Variations in target volume definition and dose to normal tissue using anatomic versus biological imaging (18F-FDG-PET) in the treatment of bone metastases : results from a 3-arm randomized phase II trial
Auteurs: Dieter Berwouts, Katrien De Wolf, Wilfried De Neve, Ana Maria Luiza Olteanu, Bieke Lambert, Bruno Speleers, Indira Madani, Piet Ost
Pagina's: 124 - 132
- A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response
Auteurs: Nora Sundahl, Katrien De Wolf, Daan De Maeseneer, Annabel Meireson, Els Goetghebeur, Pieter De Visschere, Dries Reynders, Mireille Van Gele, Lieve Brochez, Piet Ost
- The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy
Auteurs: Katrien De Wolf, Karim Vermaelen, Piet Ost
- Combined high dose radiation and pazopanib in metastatic renal cell carcinoma : a phase I dose escalation trial
Auteurs: Katrien De Wolf, Karim Vermaelen, Nora Sundahl, Lizzy De Lobel, Els Goetghebeur, Gert De Meerleer, Nicolaas Lumen, Daan De Maeseneer, Piet Ost
- Biological 18[F]-FDG-PET image-guided dose painting by numbers for painful uncomplicated bone metastases: a 3-arm randomized phase II trial
Auteurs: Dieter Berwouts, Katrien De Wolf, Bieke Lambert, Wilfried De Neve, Lizzy De Lobel, Els Goetghebeur, Bruno Speleers, Ana Maria Luiza Olteanu, Indira Madani, Piet Ost
Pagina's: 272 - 278